[
  {
    "sentence": "Magnetic resonance imaging (MRI) of the brain revealed the presence of a large posterior fossa mass with accompanying hydrocephalus (Figure 1a).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "There was evidence of leptomeningeal spread over the surface of the cerebellum and drop metastases in the distal spinal cord (Figure 1a,b).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Ki-67 proliferative index was 30%.The patient underwent resection of the majority of the mass; however, residual disease was evident within the left cerebello-pontine angle on the post-operative MRI (Figure 1c).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The proliferation index as measured by Ki-67 was approximately 30% (Figure 1d).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "An MRI showed an enlarging mass within the pons and upper medulla with an expanding lesion showing an area of cavitation and rim enhancement at its posteroinferior margin (Figure 2a).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "He showed some clinical improvement with reduction in the size of the pontine lesion after radiation; however, within three months multiple punctate and ring-enhancing lesions developed in the supra- and infratentorial regions of the brain (Figure 2b).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel b",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel b",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Upon tumour-related morbidity, tumours were removed, dissociated and reimplanted into the brains of successive recipient animals (Figure 3a).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Initially, mice implanted with the patient cells had a median time to morbidity of approximately 170 days, which reduced to approximately 78 days and 100 days in the secondary and tertiary implant generations, respectively (Figure 3b).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Positivity for OLIG2, nestin, vimentin and glial fibrillary acidic protein (GFAP) by IHC support a glial phenotype.Histological assessment of the patient tumour and matched PDX tumours was performed in order to characterise the model and ensure that the PDX faithfully recapitulated the original patient tumour (Figure 3c,d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Both the patient and the PDX tumours clustered close to each other, highlighting retention of the molecular characteristics of the patient tumour in the PDX model (Figure 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "High expression levels of the majority of the RIG-associated genes were observed in both the patient and PDX tumours in comparison to the reference cohort, supporting the finding that this case and the TK-RIG915 PDX model are mostly likely RIGs (Figure 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Copy number analysis (using methylation array data [29] and WGS) of both the patient and PDX tumours revealed hemizygous loss of chromosome 1p and homozygous deletions on chromosome 9p including a segment containing CDKN2A/B, MTAP and multiple interferon genes (Figure 6a–d).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel a",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "CIRCOS plots generated from the WGS data visually demonstrate the overarching similarities between the genetic profiles of the patient tumour and TK-RIG915 (Figure 6c,d and Figures S1 and S2).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel c",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Immunohistochemistry (IHC) for H3 K27 tri-methylation (H3K27me3) confirmed this, with both the patient and PDX tumours staining positively (Figure 7a), supporting that they did not harbour the characteristic K27M variant observed in the majority of paediatric DIPGs [33,34].",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "EGFR was not amplified (Figure 6a,b), and no mutations or deletions were found in either the patient or PDX tumours by WGS.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel a",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "EGFR expression was undetectable using IHC and transcript levels were very low in both cases compared to the reference datasets (Figure 7).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Copy number profiling indicated that TP53 and PTEN were not deleted in either the patient tumour or the PDX tumours (Figure 6a,b), and mutations in these genes were not observed by WGS.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel a",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "RNA expression analysis demonstrated unremarkable levels of TP53 and PTEN transcripts relative to both the reference subset of high-risk paediatric brain tumours and the reference set of all high-risk paediatric tumours (Figure 7b).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel b",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel b",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "These data were further supported by negative staining for p53 by IHC and weakly positive staining for PTEN typical of astrocytic tumours (Figure 7a).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "NF1 transcript levels were significantly lower in both the primary and matched TK-RIG915 PDX tumours compared to both reference sets, consistent with other tumours in the reference cohorts that had homozygous deletion of NF1 (Figure 8a).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "In addition to low NF1 expression, we identified significantly lower levels of AT-rich interactive domain 1A (ARID1A) transcripts in TK-RIG915 compared to both reference sets (Figure 8a).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "PDGFRα protein expression was also high in the patient tumour (upper panel).Further evidence that the PI3K/AKT pathway is driving growth of TK-RIG915 is supported by the high levels of AKT2 and IDH1 transcripts compared to both reference sets (Figure 8a).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "High levels of PDGFRA RNA expression, which encodes platelet derived growth factor receptor alpha (PDGFRα), compared to both reference sets were also detected in TK-RIG915 (Figure 8b) and confirmed at the protein level by IHC (Figure 8c).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel b",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel c",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel b",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel c",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Of note, despite low levels of PDGFRα transcripts in the RNAseq data from the patient tumour (Figure 8b), IHC confirmed high PDGFRα protein expression in the tissue (Figure 8c).2.7.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel b",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel c",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel b",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel c",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Both the PDX and the patient tissue were strongly positive for phosphorylated ERK1/2 (Figure 9), confirming Ras/Raf/MEK/ERK pathway activation.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Magnetic resonance imaging (MRI) of the brain revealed the presence of a large posterior fossa mass with accompanying hydrocephalus (Figure 1a).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "There was evidence of leptomeningeal spread over the surface of the cerebellum and drop metastases in the distal spinal cord (Figure 1a,b).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Ki-67 proliferative index was 30%.The patient underwent resection of the majority of the mass; however, residual disease was evident within the left cerebello-pontine angle on the post-operative MRI (Figure 1c).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The proliferation index as measured by Ki-67 was approximately 30% (Figure 1d).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "An MRI showed an enlarging mass within the pons and upper medulla with an expanding lesion showing an area of cavitation and rim enhancement at its posteroinferior margin (Figure 2a).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "He showed some clinical improvement with reduction in the size of the pontine lesion after radiation; however, within three months multiple punctate and ring-enhancing lesions developed in the supra- and infratentorial regions of the brain (Figure 2b).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel b",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel b",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Magnetic resonance imaging (MRI) of the brain revealed the presence of a large posterior fossa mass with accompanying hydrocephalus (Figure 1a).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "There was evidence of leptomeningeal spread over the surface of the cerebellum and drop metastases in the distal spinal cord (Figure 1a,b).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The patient underwent resection of the majority of the mass; however, residual disease was evident within the left cerebello-pontine angle on the post-operative MRI (Figure 1c).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The proliferation index as measured by Ki-67 was approximately 30% (Figure 1d).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "An MRI showed an enlarging mass within the pons and upper medulla with an expanding lesion showing an area of cavitation and rim enhancement at its posteroinferior margin (Figure 2a).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "He showed some clinical improvement with reduction in the size of the pontine lesion after radiation; however, within three months multiple punctate and ring-enhancing lesions developed in the supra- and infratentorial regions of the brain (Figure 2b).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel b",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel b",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Upon tumour-related morbidity, tumours were removed, dissociated and reimplanted into the brains of successive recipient animals (Figure 3a).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Initially, mice implanted with the patient cells had a median time to morbidity of approximately 170 days, which reduced to approximately 78 days and 100 days in the secondary and tertiary implant generations, respectively (Figure 3b).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Positivity for OLIG2, nestin, vimentin and glial fibrillary acidic protein (GFAP) by IHC support a glial phenotype.Histological assessment of the patient tumour and matched PDX tumours was performed in order to characterise the model and ensure that the PDX faithfully recapitulated the original patient tumour (Figure 3c,d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Upon tumour-related morbidity, tumours were removed, dissociated and reimplanted into the brains of successive recipient animals (Figure 3a).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Initially, mice implanted with the patient cells had a median time to morbidity of approximately 170 days, which reduced to approximately 78 days and 100 days in the secondary and tertiary implant generations, respectively (Figure 3b).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Histological assessment of the patient tumour and matched PDX tumours was performed in order to characterise the model and ensure that the PDX faithfully recapitulated the original patient tumour (Figure 3c,d).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Both the patient and the PDX tumours clustered close to each other, highlighting retention of the molecular characteristics of the patient tumour in the PDX model (Figure 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "High expression levels of the majority of the RIG-associated genes were observed in both the patient and PDX tumours in comparison to the reference cohort, supporting the finding that this case and the TK-RIG915 PDX model are mostly likely RIGs (Figure 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Both the patient and the PDX tumours clustered close to each other, highlighting retention of the molecular characteristics of the patient tumour in the PDX model (Figure 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "High expression levels of the majority of the RIG-associated genes were observed in both the patient and PDX tumours in comparison to the reference cohort, supporting the finding that this case and the TK-RIG915 PDX model are mostly likely RIGs (Figure 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Copy number analysis (using methylation array data [29] and WGS) of both the patient and PDX tumours revealed hemizygous loss of chromosome 1p and homozygous deletions on chromosome 9p including a segment containing CDKN2A/B, MTAP and multiple interferon genes (Figure 6a–d).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel a",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "CIRCOS plots generated from the WGS data visually demonstrate the overarching similarities between the genetic profiles of the patient tumour and TK-RIG915 (Figure 6c,d and Figures S1 and S2).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel c",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Immunohistochemistry (IHC) for H3 K27 tri-methylation (H3K27me3) confirmed this, with both the patient and PDX tumours staining positively (Figure 7a), supporting that they did not harbour the characteristic K27M variant observed in the majority of paediatric DIPGs [33,34].",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "EGFR was not amplified (Figure 6a,b), and no mutations or deletions were found in either the patient or PDX tumours by WGS.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel a",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "EGFR expression was undetectable using IHC and transcript levels were very low in both cases compared to the reference datasets (Figure 7).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Copy number profiling indicated that TP53 and PTEN were not deleted in either the patient tumour or the PDX tumours (Figure 6a,b), and mutations in these genes were not observed by WGS.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel a",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "RNA expression analysis demonstrated unremarkable levels of TP53 and PTEN transcripts relative to both the reference subset of high-risk paediatric brain tumours and the reference set of all high-risk paediatric tumours (Figure 7b).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel b",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel b",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "These data were further supported by negative staining for p53 by IHC and weakly positive staining for PTEN typical of astrocytic tumours (Figure 7a).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Copy number analysis (using methylation array data [29] and WGS) of both the patient and PDX tumours revealed hemizygous loss of chromosome 1p and homozygous deletions on chromosome 9p including a segment containing CDKN2A/B, MTAP and multiple interferon genes (Figure 6a–d).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel a",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "CIRCOS plots generated from the WGS data visually demonstrate the overarching similarities between the genetic profiles of the patient tumour and TK-RIG915 (Figure 6c,d and Figures S1 and S2).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel c",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Immunohistochemistry (IHC) for H3 K27 tri-methylation (H3K27me3) confirmed this, with both the patient and PDX tumours staining positively (Figure 7a), supporting that they did not harbour the characteristic K27M variant observed in the majority of paediatric DIPGs [33,34].",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "EGFR was not amplified (Figure 6a,b), and no mutations or deletions were found in either the patient or PDX tumours by WGS.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel a",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "EGFR expression was undetectable using IHC and transcript levels were very low in both cases compared to the reference datasets (Figure 7).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Copy number profiling indicated that TP53 and PTEN were not deleted in either the patient tumour or the PDX tumours (Figure 6a,b), and mutations in these genes were not observed by WGS.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel a",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "RNA expression analysis demonstrated unremarkable levels of TP53 and PTEN transcripts relative to both the reference subset of high-risk paediatric brain tumours and the reference set of all high-risk paediatric tumours (Figure 7b).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel b",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel b",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "These data were further supported by negative staining for p53 by IHC and weakly positive staining for PTEN typical of astrocytic tumours (Figure 7a).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "NF1 transcript levels were significantly lower in both the primary and matched TK-RIG915 PDX tumours compared to both reference sets, consistent with other tumours in the reference cohorts that had homozygous deletion of NF1 (Figure 8a).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "In addition to low NF1 expression, we identified significantly lower levels of AT-rich interactive domain 1A (ARID1A) transcripts in TK-RIG915 compared to both reference sets (Figure 8a).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "PDGFRα protein expression was also high in the patient tumour (upper panel).Further evidence that the PI3K/AKT pathway is driving growth of TK-RIG915 is supported by the high levels of AKT2 and IDH1 transcripts compared to both reference sets (Figure 8a).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "High levels of PDGFRA RNA expression, which encodes platelet derived growth factor receptor alpha (PDGFRα), compared to both reference sets were also detected in TK-RIG915 (Figure 8b) and confirmed at the protein level by IHC (Figure 8c).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel b",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel c",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel b",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel c",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Of note, despite low levels of PDGFRα transcripts in the RNAseq data from the patient tumour (Figure 8b), IHC confirmed high PDGFRα protein expression in the tissue (Figure 8c).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel b",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel c",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel b",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel c",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "NF1 transcript levels were significantly lower in both the primary and matched TK-RIG915 PDX tumours compared to both reference sets, consistent with other tumours in the reference cohorts that had homozygous deletion of NF1 (Figure 8a).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "In addition to low NF1 expression, we identified significantly lower levels of AT-rich interactive domain 1A (ARID1A) transcripts in TK-RIG915 compared to both reference sets (Figure 8a).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Further evidence that the PI3K/AKT pathway is driving growth of TK-RIG915 is supported by the high levels of AKT2 and IDH1 transcripts compared to both reference sets (Figure 8a).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel a",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "High levels of PDGFRA RNA expression, which encodes platelet derived growth factor receptor alpha (PDGFRα), compared to both reference sets were also detected in TK-RIG915 (Figure 8b) and confirmed at the protein level by IHC (Figure 8c).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel b",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel c",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel b",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel c",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Of note, despite low levels of PDGFRα transcripts in the RNAseq data from the patient tumour (Figure 8b), IHC confirmed high PDGFRα protein expression in the tissue (Figure 8c).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel b",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel c",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel b",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel c",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Both the PDX and the patient tissue were strongly positive for phosphorylated ERK1/2 (Figure 9), confirming Ras/Raf/MEK/ERK pathway activation.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Both the PDX and the patient tissue were strongly positive for phosphorylated ERK1/2 (Figure 9), confirming Ras/Raf/MEK/ERK pathway activation.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "TK-RIG915 reflects these similarities, with high expression of SOX10, ERBB3, PDGFRA, OLIG2, NKX2.2 and BRINP3 (Figure 5), which have been reported for PAs [7,62,63,64].",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The cooperative nature of the genetic alterations driving the PI3K and MEK signalling pathways in TK-RIG915 is summarised in Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "TK-RIG915 reflects these similarities, with high expression of SOX10, ERBB3, PDGFRA, OLIG2, NKX2.2 and BRINP3 (Figure 5), which have been reported for PAs [7,62,63,64].",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The cooperative nature of the genetic alterations driving the PI3K and MEK signalling pathways in TK-RIG915 is summarised in Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Graphical abstract and Figure 3a were created in BioRender (BioRender.com).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Graphical abstract and Figure 3a were created in BioRender (BioRender.com).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      }
    ]
  }
]